Yahoo · Oct 6, 2026
Why Freshworks Stock Bumped Higher Today
It's about to join a famous small-cap stock index.
NASDAQ · BLFS
BioLife Solutions, Inc.
Healthcare · Medical - Instruments & Supplies
$38.61
Up+$0.00 (+0.00%)
Updated Oct 7, 2026, 8:35 AM
SID Score
5.7/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.2B
- P/E ratio
- -215.22
- Dividend yield
- 0.00%
- 52-week range
- $17.86 – $39.76
- Volume
- 4.45M
- Avg. volume
- 367.9K
Price performance · BLFS
BLFS price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 5, 2026
BLFS closed at $38.61 after 20 trading sessions, up 9.13% for the selected period.
- Last close
- $38.61
- Period change
- +9.13%
- Period low
- $34.92
- Period high
- $39.22
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 5, 2026 | $37.16 | $38.83 | $36.95 | $38.61 | 4.45M |
| Oct 2, 2026 | $37.02 | $37.98 | $36.83 | $37.30 | 2.85M |
| Oct 1, 2026 | $38.90 | $38.90 | $36.70 | $36.78 | 919.39K |
| Sep 30, 2026 | $39.19 | $39.41 | $38.69 | $38.85 | 1.09M |
| Sep 29, 2026 | $39.17 | $39.47 | $38.735 | $39.22 | 573.54K |
| Sep 28, 2026 | $38.13 | $39.76 | $37.864 | $39.15 | 1.33M |
| Sep 25, 2026 | $38.51 | $38.68 | $38.12 | $38.49 | 998.55K |
| Sep 24, 2026 | $37.63 | $38.89 | $37.63 | $38.58 | 1.12M |
| Sep 23, 2026 | $38.04 | $38.39 | $37.32 | $37.74 | 929.66K |
| Sep 22, 2026 | $37.43 | $38.28 | $37.15 | $38.07 | 825.03K |
| Sep 21, 2026 | $36.70 | $37.36 | $36.53 | $37.18 | 406.6K |
| Sep 18, 2026 | $36.73 | $37.03 | $36.58 | $36.69 | 1.03M |
| Sep 17, 2026 | $36.67 | $36.92 | $36.20 | $36.85 | 1.57M |
| Sep 16, 2026 | $36.46 | $36.92 | $35.92 | $36.11 | 467.82K |
| Sep 15, 2026 | $35.51 | $36.53 | $35.51 | $36.39 | 914.63K |
| Sep 14, 2026 | $35.00 | $35.49 | $34.635 | $35.43 | 524.52K |
| Sep 11, 2026 | $34.92 | $35.43 | $34.79 | $34.95 | 968.02K |
| Sep 10, 2026 | $34.62 | $34.95 | $34.38 | $34.92 | 1.36M |
| Sep 9, 2026 | $35.01 | $35.62 | $34.62 | $34.93 | 1.27M |
| Sep 8, 2026 | $35.03 | $36.055 | $35.03 | $35.38 | 788.4K |
Latest BLFS news
The latest Smart Investors Daily articles mentioning BLFS.
Stock researchCompany · Overview
Company
Market Activity
Research & News
BLFS research
Overview
Company profile and research snapshot.
Company profile
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- $32.00
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 10, 2026 | Benchmark | Hold | — |
| Jul 27, 2026 | Stephens & Co. | Equal-Weight | — |
| Jul 23, 2026 | Jefferies | Hold | — |
| Jul 23, 2026 | TD Cowen | Hold | — |
| Jul 22, 2026 | Lake Street | Hold | — |
News briefing
No generated briefing is available yet.
Yahoo · Oct 6, 2026
Why Are Freshworks (FRSH) Shares Soaring Today
Shares of business software provider Freshworks (NASDAQ:FRSH) jumped 5.4% in the pre-market session after S&P Dow Jones Indices announced that the company will be added to the S&P SmallCap 600.
Yahoo · Oct 6, 2026
Repligen Completes Acquisition of BioLife Solutions
WALTHAM, Mass., Oct. 06, 2026 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ: RGEN, “Repligen”, or the “Company”), a life sciences company focused on bioprocessing technology leadership, today announced it has completed the previously announced acquisition of BioLife Solutions, Inc. (NASDAQ: BLFS, “BioLife”), a leading developer and supplier of cell processing tools and services for the cell and gene therapy market. “We are excited to welcome BioLife team members to Repligen,” said Olivier Loe
Benzinga · Oct 6, 2026
Apogee Enterprises Posts Upbeat Q2 Earnings, Joins Constellation Energy, Freshworks And Other Big Stocks Moving Higher On Tuesday
U.S. stocks rose; Apogee surged 10% on strong results and raised guidance, while Option Care, Ginkgo, PacBio and others posted double-digit gains.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
